10-K Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 FY 2019

Filing Information

Form Type	10-K
Accession Number	`0001179929-20-000026`
Period End Date	20191231
Filing Date	20200214
Fiscal Year	2019
Fiscal Period	FY
XBRL Instance	moh-12312019x10k_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 81 Income Statement 111 Cash Flow Statement 171 Stockholders Equity 38 Comprehensive Income 23

Balance Sheet 81 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.19B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.83B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.45B	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.68B	USD	Point-in-time
Preferred stock, par value (dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.95B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.41B	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.33B	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$134.00M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$149.00M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Derivative asset	`DerivativeAssetsCurrent`	$29.00M	USD	Point-in-time
Derivative asset	`DerivativeAssetsCurrent`	$476.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.97B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.46B	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$385.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentNet`	$241.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$255.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$172.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$190.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$120.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$79.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$79.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$117.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$24.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$105.00M	USD	Point-in-time
Total assets	`Assets`	$8.47B	USD	Point-in-time
Total assets	`Assets`	$7.15B	USD	Point-in-time
Total assets	`Assets`	$6.79B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.85B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.93B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.19B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.96B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$967.00M	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$664.00M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$390.00M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$455.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$211.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$249.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$241.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$18.00M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$29.00M	USD	Point-in-time
Derivative liability	`DerivativeLiabilitiesCurrent`	$476.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.25B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.27B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.02B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.24B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$231.00M	USD	Point-in-time
Finance lease liabilities	`CapitalLeaseObligationsNoncurrent`	$197.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$90.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$44.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.51B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.83B	USD	Point-in-time
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 62 million shares at each of December 31, 2019, and December 31, 2018	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value per share; 150 million shares authorized; outstanding: 62 million shares at each of December 31, 2019, and December 31, 2018	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value per share; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$175.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$643.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-8.00M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.01B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.96B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.65B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.34B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.65B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$6.79B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$7.15B	USD	Point-in-time

Income Statement 111 line items

Line Item	Tag	Value	Unit	Period
Premium revenue	`PremiumsEarnedNet`	$18.85B	USD	Annual
Premium revenue	`PremiumsEarnedNet`	$16.21B	USD	Annual
Premium revenue	`PremiumsEarnedNet`	$17.61B	USD	Annual
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$438.00M	USD	Annual
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$489.00M	USD	Annual
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$417.00M	USD	Annual
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$329.00M	USD	Annual
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	Annual
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	Annual
Service revenue	`InsuranceServicesRevenue`	$407.00M	USD	Annual
Service revenue	`InsuranceServicesRevenue`	-	USD	Annual
Service revenue	`InsuranceServicesRevenue`	$521.00M	USD	Annual
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$70.00M	USD	Annual
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$132.00M	USD	Annual
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$125.00M	USD	Annual
Total revenue	`Revenues`	$4.27B	USD	1 Quarter
Total revenue	`Revenues`	$4.66B	USD	1 Quarter
Total revenue	`Revenues`	$16.83B	USD	Annual
Total revenue	`Revenues`	$4.70B	USD	1 Quarter
Total revenue	`Revenues`	$19.88B	USD	Annual
Total revenue	`Revenues`	$4.12B	USD	1 Quarter
Total revenue	`Revenues`	$18.89B	USD	Annual
Total revenue	`Revenues`	$4.88B	USD	1 Quarter
Total revenue	`Revenues`	$4.24B	USD	1 Quarter
Total revenue	`Revenues`	$4.65B	USD	1 Quarter
Total revenue	`Revenues`	$4.19B	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.33B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.30B	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$1.59B	USD	Annual
Premium tax expenses	`PremiumTaxExpenses`	$438.00M	USD	Annual
Premium tax expenses	`PremiumTaxExpenses`	$417.00M	USD	Annual
Premium tax expenses	`PremiumTaxExpenses`	$489.00M	USD	Annual
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	Annual
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	Annual
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$348.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$137.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$99.00M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$89.00M	USD	Annual
Restructuring costs	`RestructuringCosts`	$234.00M	USD	Annual
Restructuring costs	`RestructuringCosts`	$46.00M	USD	Annual
Restructuring costs	`RestructuringCosts`	$6.00M	USD	Annual
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	$470.00M	USD	Annual
Total operating expenses	`CostsAndExpenses`	$20.44B	USD	Annual
Total operating expenses	`CostsAndExpenses`	$15.79B	USD	Annual
Total operating expenses	`CostsAndExpenses`	$17.74B	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-15.00M	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$37.00M	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-52.00M	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$1.04B	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$-555.00M	USD	Annual
Operating income (loss)	`OperatingIncomeLoss`	$1.13B	USD	Annual
Interest expense	`InterestExpense`	$118.00M	USD	Annual
Interest expense	`InterestExpense`	$87.00M	USD	Annual
Interest expense	`InterestExpense`	$115.00M	USD	Annual
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$15.00M	USD	Annual
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$-17.00M	USD	Annual
Other (income) expenses, net	`OtherNonoperatingIncomeExpense`	$61.00M	USD	Annual
Total other expenses, net	`NonoperatingIncomeExpense`	$-72.00M	USD	Annual
Total other expenses, net	`NonoperatingIncomeExpense`	$-132.00M	USD	Annual
Total other expenses, net	`NonoperatingIncomeExpense`	$-57.00M	USD	Annual
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$999.00M	USD	Annual
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-612.00M	USD	Annual
Income (loss) before income tax expense (benefit)	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$972.00M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$292.00M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$-100.00M	USD	Annual
Income tax expense (benefit)	`IncomeTaxExpenseBenefit`	$235.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$737.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$201.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$168.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-512.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$707.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$175.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$197.00M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$11.85	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$1.79	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.29	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.24	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.81	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$-9.07	USD	Annual
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.22	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.70	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.15	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.19	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$11.57	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.90	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.06	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.75	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-9.07	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.64	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.01	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.67	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$11.47	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.99	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$10.61	USD	Annual
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$3.02	USD	1 Quarter
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	62.20M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	61.10M	shares	Annual
Basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	56.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	66.60M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	56.40M	shares	Annual
Diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	64.20M	shares	Annual

Cash Flow Statement 171 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$737.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$175.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$197.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-512.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$168.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$201.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$707.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$89.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$127.00M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$178.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-10.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$6.00M	USD	Annual
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$94.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$27.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$39.00M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$46.00M	USD	Annual
Amortization of convertible senior notes and finance lease liabilities	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$5.00M	USD	Annual
Amortization of convertible senior notes and finance lease liabilities	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$32.00M	USD	Annual
Amortization of convertible senior notes and finance lease liabilities	`AmortizationOfDebtDiscountPremiumAndSaleLeasebackFinancingObligation`	$22.00M	USD	Annual
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-14.00M	USD	Annual
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$15.00M	USD	Annual
(Gain) loss on debt extinguishment	`GainsLossesOnExtinguishmentOfDebt`	$-22.00M	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-52.00M	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-15.00M	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sales of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$37.00M	USD	1 Quarter
Non-cash restructuring charges	`NoncashRestructuringCharges`	$60.00M	USD	Annual
Non-cash restructuring charges	`NoncashRestructuringCharges`	$17.00M	USD	Annual
Non-cash restructuring charges	`NoncashRestructuringCharges`	-	USD	Annual
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	$470.00M	USD	Annual
Impairment losses	`GoodwillAndIntangibleAssetImpairment`	-	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-5.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$4.00M	USD	Annual
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$21.00M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$76.00M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$530.00M	USD	Annual
Receivables	`IncreaseDecreaseInReceivables`	$-103.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-28.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-6.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$56.00M	USD	Annual
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-107.00M	USD	Annual
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$-226.00M	USD	Annual
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$263.00M	USD	Annual
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$-574.00M	USD	Annual
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$-303.00M	USD	Annual
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$341.00M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$2.00M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$45.00M	USD	Annual
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-12.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-21.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$38.00M	USD	Annual
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-34.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-15.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-16.00M	USD	Annual
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$51.00M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$804.00M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-314.00M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$427.00M	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$1.44B	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$2.54B	USD	Annual
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$2.70B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.30B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.76B	USD	Annual
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.44B	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$57.00M	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$86.00M	USD	Annual
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$30.00M	USD	Annual
Net cash received from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	-	USD	Annual
Net cash received from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	$190.00M	USD	Annual
Net cash received from sale of subsidiaries	`ProceedsFromDivestitureOfInterestInSubsidiariesAndAffiliates`	-	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$18.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$38.00M	USD	Annual
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$2.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.14B	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-293.00M	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.06B	USD	Annual
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	-	USD	Annual
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$362.00M	USD	Annual
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$240.00M	USD	Annual
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$623.00M	USD	Annual
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	-	USD	Annual
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$578.00M	USD	Annual
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	-	USD	Annual
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$578.00M	USD	Annual
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$623.00M	USD	Annual
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$549.00M	USD	Annual
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	-	USD	Annual
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$514.00M	USD	Annual
Proceeds from borrowings under term loan facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Proceeds from borrowings under term loan facility	`ProceedsFromLongTermLinesOfCredit`	-	USD	Annual
Proceeds from borrowings under term loan facility	`ProceedsFromLongTermLinesOfCredit`	$220.00M	USD	Annual
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$47.00M	USD	Annual
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	-	USD	Annual
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	$300.00M	USD	Annual
Repayment of credit facility	`RepaymentsOfLinesOfCredit`	-	USD	Annual
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfDebt`	$325.00M	USD	Annual
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from senior notes offerings, net of issuance costs	`ProceedsFromIssuanceOfDebt`	-	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLinesOfCredit`	$300.00M	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLinesOfCredit`	-	USD	Annual
Proceeds from borrowings under credit facility	`ProceedsFromLinesOfCredit`	-	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$18.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$29.00M	USD	Annual
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$11.00M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.19B	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$636.00M	USD	Annual
Net cash (used in) provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-552.00M	USD	Annual
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-418.00M	USD	Annual
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$378.00M	USD	Annual
Net (decrease) increase in cash and cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-364.00M	USD	Annual
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.91B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Cash and cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.29B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.91B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Income taxes	`IncomeTaxesPaidNet`	$240.00M	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$7.00M	USD	Annual
Income taxes	`IncomeTaxesPaidNet`	$239.00M	USD	Annual
Interest	`InterestPaidNet`	$78.00M	USD	Annual
Interest	`InterestPaidNet`	$93.00M	USD	Annual
Interest	`InterestPaidNet`	$78.00M	USD	Annual
Common stock issued in exchange for convertible senior notes	`NotesIssued1`	$193.00M	USD	Annual
Common stock issued in exchange for convertible senior notes	`NotesIssued1`	$131.00M	USD	Annual
Common stock issued in exchange for convertible senior notes	`NotesIssued1`	-	USD	Annual
Component of convertible senior notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	$-23.00M	USD	Annual
Component of convertible senior notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	-	USD	Annual
Component of convertible senior notes allocated to additional paid-in capital, net of income taxes	`NotesIssuedFairValueAdjustmentIncreaseDecrease`	$-32.00M	USD	Annual
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	Annual
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	Annual
Net increase to additional paid-in capital	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$161.00M	USD	Annual
Common stock used for stock-based compensation	`StockIssued1`	$6.00M	USD	Annual
Common stock used for stock-based compensation	`StockIssued1`	$7.00M	USD	Annual
Common stock used for stock-based compensation	`StockIssued1`	$22.00M	USD	Annual
Common stock purchases not settled at end of period	`CommonStockPurchasesNotSettledAtEndOfPeriod`	-	USD	Annual
Common stock purchases not settled at end of period	`CommonStockPurchasesNotSettledAtEndOfPeriod`	$7.00M	USD	Annual
Common stock purchases not settled at end of period	`CommonStockPurchasesNotSettledAtEndOfPeriod`	-	USD	Annual
Decrease in carrying amount of assets	`IncreaseDecreaseinCarryingAmountofAssets`	-	USD	Annual
Decrease in carrying amount of assets	`IncreaseDecreaseinCarryingAmountofAssets`	-	USD	Annual
Decrease in carrying amount of assets	`IncreaseDecreaseinCarryingAmountofAssets`	$-327.00M	USD	Annual
Decrease in carrying amount of liabilities	`GainLossonDispositionofLiabilities`	$85.00M	USD	Annual
Decrease in carrying amount of liabilities	`GainLossonDispositionofLiabilities`	-	USD	Annual
Decrease in carrying amount of liabilities	`GainLossonDispositionofLiabilities`	-	USD	Annual
Transaction costs	`DispositionofBusinessTransactionCosts`	-	USD	Annual
Transaction costs	`DispositionofBusinessTransactionCosts`	$15.00M	USD	Annual
Transaction costs	`DispositionofBusinessTransactionCosts`	-	USD	Annual
Cash received from buyers	`DispositionofBusinessReceivablefromBuyer`	-	USD	Annual
Cash received from buyers	`DispositionofBusinessReceivablefromBuyer`	-	USD	Annual
Cash received from buyers	`DispositionofBusinessReceivablefromBuyer`	$242.00M	USD	Annual
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-52.00M	USD	1 Quarter
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	1 Quarter
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	-	USD	Annual
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$37.00M	USD	1 Quarter
Loss on sale of subsidiaries, net of gain	`GainLossOnSaleOfBusiness`	$-15.00M	USD	Annual
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	Annual

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`SharesOutstanding`	59.30M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	55.80M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.96B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.34B	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$1.65B	USD	Point-in-time
Net income (loss)	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$707.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$168.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$201.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$175.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$737.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$-512.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$197.00M	USD	1 Quarter
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$54.00M	USD	Annual
Exchange of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	-	USD	Annual
Exchange of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$108.00M	USD	Annual
Exchange of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature`	$161.00M	USD	Annual
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.00M	USD	Annual
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-3.00M	USD	Annual
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$12.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$47.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$37.00M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$42.00M	USD	Annual
Partial termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-550.00M	USD	Annual
Partial termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-514.00M	USD	Annual
Conversion of convertible senior notes	`AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt`	$4.00M	USD	Annual
Ending Balance (in shares)	`SharesOutstanding`	59.30M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	55.80M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Ending Balance	`StockholdersEquity`	$1.96B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.34B	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$1.65B	USD	Point-in-time

Comprehensive Income 23 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$737.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$202.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$201.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$168.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-512.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$707.00M	USD	Annual
Net income (loss)	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$196.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$107.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$175.00M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$197.00M	USD	1 Quarter
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-5.00M	USD	Annual
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$16.00M	USD	Annual
Unrealized investment income (loss)	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-3.00M	USD	Annual
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$4.00M	USD	Annual
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-2.00M	USD	Annual
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-1.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-2.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-3.00M	USD	Annual
Other comprehensive income (loss), net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$12.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$705.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$749.00M	USD	Annual
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-515.00M	USD	Annual

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.